BRIEF

on Ondine Biomedical Inc (LON:OBIMF)

Ondine Biomedical Inc Introduces Steriwave Technology in Australia

Ondine Biomedical Inc., a Canadian life sciences firm, announced that Mater Hospital in North Sydney has implemented Steriwave® technology, marking its debut in Australia. This innovative light-activated antimicrobial treatment aims to prevent the spread of hospital-acquired infections (HAIs).

Professor Frances Boyle AM highlighted the significance of the technology for patients, especially those weak and immunocompromised, by providing a rapid, non-antibiotic method for nasal decolonization. This initiative at Mater Hospital, a part of St. Vincent's Health Australia Group, represents a significant step in leveraging medical technology to enhance patient safety.

In a related event, Dr. John Street presented research at the 35th Annual Scientific Meeting of the Spine Society of Australia, showing a significant reduction in surgical site infections and cost savings when using Steriwave in pre-surgical procedures at Vancouver General Hospital.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Ondine Biomedical Inc news